当前位置:首页 期刊杂志

Association of chronic obstructive pulmonary disease with mild cognitive impairm

时间:2024-12-23

lNTRODUCTlON

Chronic obstructive pulmonary disease (COPD) is a progressive multicomponent lung disease that occurs more commonly in the elderly[1]. It is characterised by a partially irreversible chronic obstruction of lung airflow resulting in an abnormal decrease in blood oxygen levels, potentially leading to cognitive dysfunction[2]. Various studies have estimated that the prevalence of cognitive impairment in COPD patients ranges from 16% to 57%[3,4]. A prior review of 17 individual studies by Yohannes[5] showed that 32% of COPD patients showed some signs of cognitive dysfunction, with no less than 25% of patients showing at least mild cognitive impairment (MCI).

It took a long time to find myself, and I had to live alone to do it. But I am not lonely. I am free for the first time in my life. I am Tandaleah, the Fire Goddess of the Volcano, spelled with two Ds and I m living happily ever after.

Cognitive impairment in COPD patients may compromise their capability to self-care and adhere to treatment regimens, making the relationship between COPD and cognitive impairment important for devising therapeutic approaches for COPD[6,7]. Some studies have focused on the relationship between COPD and neurologic function, but with inconsistent conclusions[8]. Data based on the Atherosclerosis Risk in Communities study showed that reduced lung function was associated with poor cognitive performance and higher risk of dementia hospitalization[9]. Data based on Taiwanese National Health Insurance Research Database showed that COPD patients exhibited a 1.27-fold higher risk of developing dementia[10].

The time that I ve wasted is my biggest regretSpent in these places I will never forget.Just sitting and thinking about the things that I ve doneThe crying, the laughing, the hurt and the fun.

No sooner did the princess cast her eyes on the petticoats than she declared they were even more beautiful than the mantle, and that she would give the maiden whatever price she wanted for them

We included studies that:(1) Investigated the association between COPD and a risk of MCI or dementia; (2) adopted a definite outcome of cognitive impairment or dementia in COPD and non-COPD subjects; (3) reported raw values necessary to calculate odds ratios (OR) or hazard ratios(HRs) for the incidence of cognitive impairment or dementia; (4) contained case controls, were prospective or retrospective-cohort, or had a cross-sectional design; and (5) compared the association between COPD and non-COPD patients.

Mean differences (MDs) with 95% confidence intervals (CIs) were calculated for continuous outcomes.For categorical outcomes, ORs and HRs with 95%CIs were calculated to estimate pooled findings.Heterogeneity between studies (measurable heterogeneity) was evaluated usingstatistics. Ifvalues> 50%, a random-effects model was applied, otherwise a fixed-effect model was applied. Statistical analyses were performed using Review Manager software (Version 5.3, Copenhagen:The Nordic Cochrane Centre, The Cochrane Collaboration 2014).

MATERlALS AND METHODS

Search strategy

Our meta-analysis was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines[13]. We conducted a comprehensive search using PubMed,Embase, Google Scholar, and Cochrane Library online databases for articles published prior to March 31, 2021. The following key terms were used:“Chronic Obstructive Pulmonary Disease” OR “COPD”OR “Chronic Obstructive Airway Disease” OR “COAD” AND “Mild Cognitive impairment” OR “MCI”OR “Cognitive dysfunction” OR “Cognitive decline” AND “Dementia”. Studies cited by articles that met the inclusion criteria were manually searched to identify additional eligible studies. Study eligibility was not restricted based on language, sex, or publication year. Systematic reviews, conference abstracts,and editorials were excluded due to insufficient data presentation details.

Eligibility criteria

I was willing to give him that pleasure, but I was afraid that he wouldn t be able to find the way here by himself, so I made myself ready to go with him

We excluded studies that:(1) Did not report relevant outcomes; or (2) were full-text inaccessible.

Data collection and analysis

All eligible studies were separately screened by two reviewers to determine whether they met the inclusion criteria. Screening was first conducted at the abstract content level, with relevant studies further investigated at the full-text level. Articles published in languages other than English were machine-translated using Google Translate, with the translated version reviewed. The following information was extracted from the included studies for summarization and analysis:Author, year,study design type, group investigated, sample size, diagnostic criteria for COPD, adjusted confounder for calculating pooled ratio, MCI prevalence, dementia prevalence, and scales used for cognitive assessment.

Quality assessment

Study quality was assessed independently by two separate reviewers using the Newcastle-Ottawa Scale(NOS)[14], which examined three components:Selection, comparability, and ascertainment of outcome.Disagreements were resolved through discussion.

So... Maybe... Maybe he had some things he liked to do. Life isn t simple. It s complicated. We re all just thrown in here together in a world full of chaos1(,) and confusion, a world full of questions and no answers, with Death always lingering(,) around the corner.

Publication bias

Publication bias was assessed using Funnel plot analysis and Egger’s regression test[15,16].

Statistical analysis

To our knowledge, there has only been one published meta-analysis investigating the statistical association of COPD with cognition dysfunction. Zhang[11] concluded that COPD patients had an elevated risk of cognitive dysfunction. Similarly, only one single meta-analysis has looked at the relationship between COPD and dementia. Pooling data from three studies, Wang[12] showed that COPD patients faced a higher risk of developing dementia. However, these important clinical questions have not been investigated in a more thorough and conclusive manner. As such, we conducted a comprehensive systematic review and meta-analysis to investigate the association between COPD and the risk of MCI and dementia.

RESULTS

Literature search

Our findings revealed an elevated risk for the occurrence of MCI and dementia in COPD patients.Proper clinical management and attention are required to prevent and control MCI and dementia incidence in COPD patients.

Properties and characteristics of included studies

Relevant study data, including the diagnostic criteria for COPD, sample size, and disease assessment scales for all the 27 included studies[3,4,10,17-40] are shown in Table 1. The included studies were published between 1996 and 2020, and study sample sizes ranged from 20 to 243420 subjects. Ten studies[17,19-22,28,29,34,35,39] were case-controlled, ten were cross-sectional[3,4,24-26,32,36-38,40], four were prospective-cohort[18,27,30,31], and three were retrospective-cohort[10,23,33]. Seventeen studies[4,17-22,25,31,32,34-40] reported cognitive impairment data based on the mini-mental state examination(MMSE) scoring system. Twenty-two studies used the GOLD criteria, three[10,23,33] reported the ICD-9 CM criteria, and two[3,26]followed the standardized guidelines for COPD diagnosis. The quality score was high in twelve studies, medium in seven, and low in six (Supplementary Table 1). The assessment criteria involving the NOS uses three broad criteria:Selection, comparability, and exposure, where the selection defines and analyses the cases and control subjects included in the study, comparability defines the matching or comparison of cases and control subjects for better empirical investigation, and exposure determines whether the study was conducted in a blinded or unbiased manner along with the response of the subjects.

Association of COPD with MCI risk

Ten studies[3,18,19,24,26-29,33,37] detailing 71174 COPD patients and 22082 control subjects investigated the association of COPD with MCI risk. Our meta-analysis indicated a strong association between COPD and an increased MCI incidence risk (OR = 2.11, 95%CI:1.32-3.38). A significant degree of heterogeneity was observed (= 99%). Using a random effects model, we demonstrated that COPD patients were 1.26 times more susceptible to MCI compared to non-COPD controls (Figure 2A).

Adjusted HRs for MCI risk in COPD patients

Pooling adjusted HRs from four studies[3,18,27,28] investigating the relationship between COPD and MCI incidence revealed a significant association (HR = 1.22, 95%CI:-1.18 to -1.27;= 26%] (Figure 2B).

Association of COPD with risk of dementia

Seven studies[10,18,23,24,27,28,30] involving 108606 COPD patients and 347939 control subjects, investigated the relationship between COPD and dementia risk. Pooling these data showed a borderline trend for an increased dementia risk in COPD patients compared to non-COPD control patients (OR = 1.16,95%CI:0.98-1.37). A high degree of heterogeneity was observed (= 94%). Our meta-analysis showed that COPD patients were more susceptible to dementia (Figure 3A).

Then she spoke3 to him and said, The Great Spirit felt sorry for you, because you would not be comforted, so he let me come back to you, but you must not stretch out your hand to touch me till we have seen the rest of our people

Adjusted HRs for dementia risk in COPD patients

Pooling adjusted HRs from six studies[10,18,23,27,28,30] investigating the relationship between COPD and dementia incidence revealed a significant association (HR = 1.32, 95%CI:-1.22 to -1.43; I:99%)(Figure 3B).

22.In losing the drops of blood the Princess had become weak and powerless: The princess has apparently78 always depended on her mother s protection and guidance. Now that she has left it behind, she is no longer under anyone else s protection. Return to place in story.

MMSE score in COPD and non-COPD patients

Seventeen studies[4,17-22,32,35-40,25,31,34] involving 1392 COPD patients and 5097 control subjects,reported mean MMSE score data for both COPD and non-COPD patients. Pooling these results showed a significant lower MMSE score in COPD patients compared to controls (MD = -1.68, 95%CI:-2.66 to -0.71] (Figure 4). A high degree of heterogeneity among these seventeen studies was observed (= 96%).

Publication bias

In Brother and Sister, the tale blatantly135 makes the stepmother the evil witch who persecutes136 the children. There is no differentiation137 between the stepmother and the witch. Return to place in story.

From a clinical approach, COPD can lead to pulmonary encephalopathy, hypoxemia, and inflammation, all of which may impact brain function[42]. Indeed, COPD patients exhibit a unique neurophysiological profile stemming from neurotoxicity featuring deficits of attention, motor, memory,and cognitive domain executive function[4]. Interestingly, the relationship between COPD and dementia persists even after accounting for the presence of vascular disease, suggesting that COPD is an independent predictor of dementia.

DlSCUSSlON

This study is the first systematic review and meta-analysis examining the association between COPD and the risk of MCI and dementia. We found that patients with COPD are 2.11 times more susceptible to MCI and 1.16 times more susceptible to dementia. Moreover, lower MMSE scores were observed in COPD patients, indicating greater cognitive impairment.

COPD-associated neurological impairment and dementia put a great burden on the patients and the healthcare system. In particular, declining cognition leads to COPD patients requiring more assistance for daily activities[41]. Our analysis was performed based on the reported adjustments within individual studies for confounding factors such as age, sex, smoking, body mass index, education level,diabetes mellitus, and previous history of stroke or cardiovascular disease[10,23,27,28,30]. Studies by Thakur[33], Singh[26], and Martinez[24] reported data as ORs for adjusted confounders and therefore were not included in the calculations for pooled incidence for MCI or dementia.

“Who should know better than I do?” said the animal, while his eyes sparkled. “I was born and brought up there, and used to run about the snow-covered plains.”

Our findings are consistent with the previous literature[5,11,12,42,43]. However, the available literature on the relationship between dementia and COPD remains limited, as only seven studies were found for this meta-analysis. Our study also had several other limitations. The included studies had different designs, which may be one of the leading causes of heterogeneity. Additional sources of heterogeneity may include different geographical population, variation in the diagnostic criteria of COPD, and diversity in the factors undertaken for the multivariate analysis of each included studies.The included studies also lacked long-term follow-up data, as well as data that would facilitate subgroup analysis based on co-morbidities, age, and gender. Finally, different studies varied on how they assessed and diagnosed COPD and cognitive impairment.

CONCLUSlON

Our meta-analysis revealed an elevated risk for MCI and dementia in COPD patients. Proper clinical management and attention are necessary to prevent or mitigate the incidence of MCI and dementia in COPD patients.

Egger’s tests did not show any significant publication bias for the examined comparisons. Figure 5 shows the funnel plot of the studies included in each comparison. However, no significant publication biases were observed for the association of COPD with risk of MCI and dementia, MCI risk in COPD patients, dementia risk in COPD patients, and comparison of MMSE score between the COPD and control groups.

ARTlCLE HlGHLlGHTS

Research background

Chronic obstructive pulmonary disease (COPD) is a common public health issue that has been linked to cognitive dysfunction. No clear evidence is available for the relationship between COPD and mild cognitive impairment (MCI) and dementia risk.

Research motivation

To our knowledge, there has only been one published meta-analysis with limited number studies investigating the statistical association of COPD with cognition dysfunction.

Research objectives

The current meta-analysis was performed to investigate the relationship between COPD and MCI and dementia risk.

Research methods

A comprehensive search was performed using PubMed, Embase, Google Scholar, and Cochrane Library online databases for articles published prior to March 31, 2021.

Research results

Twenty-seven studies met all the inclusion criteria. Meta-analysis yielded a strong association between COPD and an increased risk of MCI incidence. It also revealed a borderline trend for an increased dementia risk in COPD patients. A significant lower MMSE score in COPD patients was noted.

If you do not come, and if I do not hear from you, then I shall know that you could never be happy so far from the people and the country which you love

Research conclusions

Preliminary screening of PubMed, Embase, Google Scholar, and Cochrane Library databases yielded 234 results (Figure 1). Review of article title and abstract resulted in 72 remaining studies. Full-text review further excluded 45, leaving 27 studies[3,4,10,17-40] that were ultimately included in the metaanalysis.

Research perspectives

Further large prospective observational studies are needed to strengthen the evidence on this important subject.

In one moment they all fell hopelessly in love with her, and longed ardently4 to have the girl for their wife; but hardly had they with one breath expressed their desire than, mad with jealousy5, they drew their swords and all three set upon each other

Zhao LY conceived and designed the study; Zhao LY and Zhou XL were involved in literature search and data collection; Zhao LY analyzed the data; Zhao LY and Zhou XL wrote the paper; Zhao LY edited the manuscript; all authors read and approved the final manuscript.

The authors deny any conflict of interest for this article.

The authors have read the PRISMA 2009 Checklist, and manuscript was prepared and revised according to the PRISMA 2009 Checklist.

This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BYNC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See:https://creativecommons.org/Licenses/by-nc/4.0/

China

Li-Ying Zhao 0000-0002-8106-609X; Xue-Lai Zhou 0000-0002-6652-7038.

Fan JR

Wang TQ

Yu HG

免责声明

我们致力于保护作者版权,注重分享,被刊用文章因无法核实真实出处,未能及时与作者取得联系,或有版权异议的,请联系管理员,我们会立即处理! 部分文章是来自各大过期杂志,内容仅供学习参考,不准确地方联系删除处理!